Aclaris Therapts (ACRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,256 | 25,402 | 30,357 | 24,570 | 47,651 |
| Marketable Securities | 70,656 | 74,404 | 74,957 | 89,024 | 80,071 |
| Receivables | 4,680 | 194 | 250 | 12,357 | 343 |
| TOTAL | $100,592 | $104,202 | $108,790 | $125,951 | $132,330 |
| Non-Current Assets | |||||
| PPE Net | 811 | 868 | 942 | 1,008 | 1,133 |
| Investments And Advances | 71,297 | 81,084 | 85,211 | 90,302 | 45,714 |
| Other Non-Current Assets | 2,834 | 2,993 | 3,151 | 3,066 | 3,217 |
| TOTAL | $74,942 | $84,945 | $89,304 | $94,376 | $50,064 |
| Total Assets | $175,534 | $189,147 | $198,094 | $220,327 | $182,394 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,187 | 8,797 | 6,354 | 4,690 | 7,662 |
| Accrued Expenses | 9,784 | 11,411 | 8,572 | 20,333 | 4,722 |
| TOTAL | $25,631 | $26,839 | $21,514 | $31,596 | $18,816 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,925 | 3,914 | 3,888 | 3,890 | 3,765 |
| Other Non-Current Liabilities | 12,311 | 12,351 | 13,308 | 13,139 | 12,245 |
| TOTAL | $29,803 | $30,569 | $32,514 | $33,177 | $33,427 |
| Total Liabilities | $55,434 | $57,408 | $54,028 | $64,773 | $52,243 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 108,345 | 108,332 | 108,281 | 107,919 | 71,431 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -947,989 | -933,375 | -917,946 | -902,861 | -806,309 |
| Other shareholders' equity | 597 | 482 | 434 | 97 | 427 |
| TOTAL | $120,100 | $131,739 | $144,066 | $155,554 | $130,151 |
| Total Liabilities And Equity | $175,534 | $189,147 | $198,094 | $220,327 | $182,394 |